Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Paclitaxel|DRUG: Vinorelbine|DRUG: T-DM1
Sponsor: Swiss Group for Clinical Cancer Research